GlassScriptPhysician profile
Marc J Michaud
NPI 1063491702
$16,538.87
in general payments reported to CMS, 2019-2025
32 companies · $2,367 in 2025
The $2,367 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,541 · 2020: $482 · 2021: $2,631 · 2022: $2,813 · 2023: $1,334 · 2024: $1,371 · 2025: $2,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,688 · Travel and Lodging: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,688.26 |
| Travel and Lodging | $1,383.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,960.25 | 2019 | |
| Smith+Nephew, INC. | $2,122.53 | 2019-2025 | Pico, Grafix Pl, Grafix |
| Stryker Corporation | $1,660.50 | 2019-2025 | Infinity, Incompass Total Ankle System, Dart-Fire |
| Cerapedics INC. | $1,348.71 | 2021-2023 | I-Factor Peptide Enhanced Bone Graft |
| Arthrex, INC. | $1,254.00 | 2021-2023 | |
| Kairos Surgical INC | $640.87 | 2021-2025 | |
| Innovation Technologies INC | $635.66 | 2022-2025 | Irrisept |
| Paragon 28, INC. | $574.63 | 2021-2025 | Portfolio, Additive Orthopedics, Mtp |
| Pacira Pharmaceuticals Incorporated | $558.81 | 2019-2025 | Iovera, Zilretta, Exparel |
| Ferring Pharmaceuticals INC. | $479.69 | 2019-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $384.93 | 2019-2022 | |
| Bioventus LLC | $286.69 | 2023-2025 | Xcell, Durolane, Exogen Ultrasound Bone Healing System |
| Alphatec Spine, INC | $194.14 | 2024 | Other - Miscellaneous |
| Wright Medical Technology, INC. | $175.32 | 2019-2020 | |
| Janssen Biotech, INC. | $142.42 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $141.37 | 2024-2025 | |
| Arthrosurface Incorporated | $126.95 | 2019 | |
| Zimmer Biomet Holdings, INC. | $120.52 | 2022-2025 | Tapestry, Comprehensive Shoulder System |
| Bone Support INC. | $117.65 | 2025 | Cerament G, Ceramentbone Void Filler |
| Pacira Therapeutics, INC. | $117.32 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $84.77 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $78.29 | 2022-2025 | Dupixent |
| Fidia Pharma USA INC. | $69.44 | 2025 | Hymovis, Triluron |
| Takeda Pharmaceuticals U.S.A., INC. | $65.61 | 2023-2024 | Entyvio, Gattex |
| Endo USA, INC. | $54.01 | 2024-2025 | Xiaflex |
| Radius Health, INC. | $33.37 | 2022 | |
| Getinge USA Sales, LLC | $24.66 | 2022 | |
| Pfizer INC. | $22.29 | 2024 | |
| Orthofix Medical, INC. | $18.80 | 2024 | Physio-Stim |
| Atricure, INC. | $18.53 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Genzyme Corporation | $15.03 | 2024 | |
| Ucb, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Michaud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.